Market Overview:
The global sterile injectables market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for biologics and biosimilars, and growing number of approvals for new products. Based on type, the global sterile injectables market is segmented into large molecules and small molecules. The large molecule segment is expected to account for the majority share of the global sterile injectables market in 2018. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to increasing demand for monoclonal antibodies (mAbs) and other large molecules used in therapies such as cancer, diabetes, cardiovascular diseases, central nervous systems (CNS), infectious disorders, and musculoskeletal disorders. Based on application, the global sterile injectables market is divided into five segments: cancer therapeutics; diabetes therapeutics; cardiovascular diseases therapeutics; CNS therapeutics; and other applications (infectious disorders & musculoskeletal disorders). The cancer therapeutics segment accounted for the largest share of this market in 2017 owing to rising incidence rates of various types of cancers across regions worldwide coupled with increasing adoption rates of novel anticancer drugs/therapies by physicians globally.
Product Definition:
A sterile injectable is a drug or other therapeutic agent that is injected into a patient, usually by means of an injection. The term "sterile injectables" generally refers to pharmaceuticals that are in liquid form and are intended for injection into the body intravenously (into a vein), intramuscularly (into muscle), or subcutaneously (under the skin).
Large Molecules:
Large molecules are injectable drugs that are made up of more than 50% amide groups. They have a high volume and low surface area which results in lower permeability to the surrounding medium. The large size of these molecules helps them to remain longer in the blood circulation and tissue, thus increasing its duration of action.
Small Molecules:
Small molecules are the most basic and common type of injectable drugs. They can be administered by either intravenous or subcutaneous route. The small size of these molecules allows them to easily pass through the cell membranes and reach their target cells, which in turn enhances their therapeutic effect. These are available in both non-sterile (generally used) as well as sterile formulae depending on the regulatory requirements of a particular country/ region.
Application Insights:
The cancer segment dominated the global sterile injectables market in 2017, accounting for over 41.0% share of the total revenue. Increasing prevalence of cancer across the globe is expected to be a major factor driving growth during the forecast period. According to WHO, it is estimated that around 1 in 6 women and 1 in 5 men are estimated to develop some form of cancer during their lifetime globally. Rising cases of breast and prostate cancers are expected to further boost demand for these products over the forecast period as they require frequent medication throughout treatment course duration.
According to data published by NCBI, around 8-12% patients suffering from chronic diseases such as heart disease or diabetes require regular injections with drugs every 2-4 weeks throughout their life span which will increase demand for sterilized vials & syringes respectively especially among diabetic patients undergoing long term treatment course at hospitals or clinics where multiple daily doses become tiresome.
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending in this region are some of the factors responsible for its large share. In addition, increasing R&D activities by various companies to develop novel products and improve existing ones is also expected to propel growth over the forecast period.
Asia Pacific is estimated to be one of the fastest growing regions during the forecast period owing to rising disposable income and improving economic conditions especially in emerging countries such as China & India which are major consumers of these products. Growing target population base along with an increase in life expectancy has also contributed significantly towards regional growth rate over past few years.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The increase in the incidence of chronic diseases is expected to drive the demand for sterile injectables in the coming years.
- Technological advancements: The sterile injectables market is witnessing rapid technological advancements, with new products being launched regularly. This is helping to improve patient outcomes and increase compliance rates. Such technological advances are likely to fuel market growth in the coming years.
- Rising geriatric population: A large number of people are now living beyond 65 years, which has led to a rise in the geriatric population worldwide. This group is particularly susceptible to various chronic diseases, such as cancer and diabetes mellitus, which require regular injections for treatment purposes These factors are expected to propel demand for sterile injectables over the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Sterile Injectables Market Research Report
By Type
Large Molecules, Small Molecules
By Application
Cancer, Diabetes, Cardiovascular Diseases, Central Nervous Systems, Infectious Disorders, Musculoskeletal
By Companies
Baxter International Inc, AstraZeneca plc, Merck & Co., Inc, Novartis AG, Johnson & Johnson Services, Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Sterile Injectables Market Report Segments:
The global Sterile Injectables market is segmented on the basis of:
Types
Large Molecules, Small Molecules
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Diabetes, Cardiovascular Diseases, Central Nervous Systems, Infectious Disorders, Musculoskeletal
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter International Inc
- AstraZeneca plc
- Merck & Co., Inc
- Novartis AG
- Johnson & Johnson Services, Inc
Highlights of The Sterile Injectables Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Large Molecules
- Small Molecules
- By Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sterile Injectables Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sterile injectables are medications that are injected into a patient's body without the risk of infection. Sterile injectables can be used to treat a variety of medical conditions, including cancer.
Some of the key players operating in the sterile injectables market are Baxter International Inc, AstraZeneca plc, Merck & Co., Inc, Novartis AG, Johnson & Johnson Services, Inc.
The sterile injectables market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sterile Injectables Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sterile Injectables Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sterile Injectables Market - Supply Chain
4.5. Global Sterile Injectables Market Forecast
4.5.1. Sterile Injectables Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sterile Injectables Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sterile Injectables Market Absolute $ Opportunity
5. Global Sterile Injectables Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sterile Injectables Market Size and Volume Forecast by Type
5.3.1. Large Molecules
5.3.2. Small Molecules
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sterile Injectables Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sterile Injectables Market Size and Volume Forecast by Application
6.3.1. Cancer
6.3.2. Diabetes
6.3.3. Cardiovascular Diseases
6.3.4. Central Nervous Systems
6.3.5. Infectious Disorders
6.3.6. Musculoskeletal
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sterile Injectables Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sterile Injectables Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sterile Injectables Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sterile Injectables Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sterile Injectables Demand Share Forecast, 2019-2026
9. North America Sterile Injectables Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sterile Injectables Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sterile Injectables Market Size and Volume Forecast by Application
9.4.1. Cancer
9.4.2. Diabetes
9.4.3. Cardiovascular Diseases
9.4.4. Central Nervous Systems
9.4.5. Infectious Disorders
9.4.6. Musculoskeletal
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sterile Injectables Market Size and Volume Forecast by Type
9.7.1. Large Molecules
9.7.2. Small Molecules
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sterile Injectables Demand Share Forecast, 2019-2026
10. Latin America Sterile Injectables Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sterile Injectables Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sterile Injectables Market Size and Volume Forecast by Application
10.4.1. Cancer
10.4.2. Diabetes
10.4.3. Cardiovascular Diseases
10.4.4. Central Nervous Systems
10.4.5. Infectious Disorders
10.4.6. Musculoskeletal
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sterile Injectables Market Size and Volume Forecast by Type
10.7.1. Large Molecules
10.7.2. Small Molecules
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sterile Injectables Demand Share Forecast, 2019-2026
11. Europe Sterile Injectables Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sterile Injectables Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sterile Injectables Market Size and Volume Forecast by Application
11.4.1. Cancer
11.4.2. Diabetes
11.4.3. Cardiovascular Diseases
11.4.4. Central Nervous Systems
11.4.5. Infectious Disorders
11.4.6. Musculoskeletal
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sterile Injectables Market Size and Volume Forecast by Type
11.7.1. Large Molecules
11.7.2. Small Molecules
11.8. Basis Pint Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sterile Injectables Demand Share, 2019-2026
12. Asia Pacific Sterile Injectables Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sterile Injectables Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sterile Injectables Market Size and Volume Forecast by Application
12.4.1. Cancer
12.4.2. Diabetes
12.4.3. Cardiovascular Diseases
12.4.4. Central Nervous Systems
12.4.5. Infectious Disorders
12.4.6. Musculoskeletal
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sterile Injectables Market Size and Volume Forecast by Type
12.7.1. Large Molecules
12.7.2. Small Molecules
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sterile Injectables Demand Share, 2019-2026
13. Middle East & Africa Sterile Injectables Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sterile Injectables Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sterile Injectables Market Size and Volume Forecast by Application
13.4.1. Cancer
13.4.2. Diabetes
13.4.3. Cardiovascular Diseases
13.4.4. Central Nervous Systems
13.4.5. Infectious Disorders
13.4.6. Musculoskeletal
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sterile Injectables Market Size and Volume Forecast by Type
13.7.1. Large Molecules
13.7.2. Small Molecules
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sterile Injectables Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sterile Injectables Market: Market Share Analysis
14.2. Sterile Injectables Distributors and Customers
14.3. Sterile Injectables Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Baxter International Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AstraZeneca plc
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck & Co., Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis AG
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Johnson & Johnson Services, Inc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
